Publications by authors named "Sarah C Gilbert"

100Publications

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Lancet 2021 01 8;397(10269):99-111. Epub 2020 Dec 8.

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address:

View Article and Find Full Text PDF
January 2021

A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.

Sci Adv 2020 06 10;6(24):eaba8399. Epub 2020 Jun 10.

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.

View Article and Find Full Text PDF
June 2020

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule.

Sci Rep 2020 03 31;10(1):5716. Epub 2020 Mar 31.

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.

View Article and Find Full Text PDF
March 2020

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats.

NPJ Vaccines 2019 18;4:44. Epub 2019 Oct 18.

6Centre for Tropical Medicine and Global Health, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford, OX3 7FZ UK.

View Article and Find Full Text PDF
October 2019

Vaccine platforms for the prevention of Lassa fever.

Immunol Lett 2019 11 23;215:1-11. Epub 2019 Apr 23.

The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK. Electronic address:

View Article and Find Full Text PDF
November 2019

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.

Vaccine 2017 08 30;35(35 Pt A):4461-4464. Epub 2017 May 30.

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom; Kenya Medical Research Institute-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya; The Pirbright Institute, Woking GU24 0NF, United Kingdom.

View Article and Find Full Text PDF
August 2017

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.

Sci Rep 2017 04 19;7:46621. Epub 2017 Apr 19.

The Jenner Institute Laboratories, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.

View Article and Find Full Text PDF
April 2017

Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector.

Methods Mol Biol 2017 ;1581:97-119

The Jenner Institute, University of Oxford, Research Bldg., Old Road Campus, ORCRB, Oxford, OX3 7DQ, UK.

View Article and Find Full Text PDF
February 2018

Simian adenoviruses as vaccine vectors.

Future Virol 2016 Sep 15;11(9):649-659. Epub 2016 Sep 15.

Jenner Institute, ORCRB, University of Oxford, Off Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK.

View Article and Find Full Text PDF
September 2016

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.

EBioMedicine 2016 Jun 28;8:277-290. Epub 2016 Apr 28.

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Melbourne Sexual Health Centre, Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, Australia; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Parkville, Australia. Electronic address:

View Article and Find Full Text PDF
June 2016

Recombinant modified vaccinia virus Ankara-based malaria vaccines.

Expert Rev Vaccines 2016 29;15(1):91-103. Epub 2015 Oct 29.

a The Jenner Institute , University of Oxford , Oxford , UK.

View Article and Find Full Text PDF
September 2016

Adenovirus-vectored Ebola vaccines.

Authors:
Sarah C Gilbert

Expert Rev Vaccines 2015 11;14(10):1347-57. Epub 2015 Aug 11.

a University of Oxford, The Jenner Institute, ORCRB, Oxford OX3 7DQ, UK.

View Article and Find Full Text PDF
June 2016

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.

PLoS One 2015 8;10(6):e0128626. Epub 2015 Jun 8.

The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, United Kingdom.

View Article and Find Full Text PDF
February 2016

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

N Engl J Med 2016 Apr 28;374(17):1635-46. Epub 2015 Jan 28.

From the Jenner Institute and Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford (K.E., T.R., N.V., G.B., D.W., T.L., E.B.I., R.P., C.M.T., N.J.E., G.L., J.J., M.G., A.M., M.W., I.P., N.L., R.R., F.H., C.B., K.S.-D., J.P., E.B., A.J.P., S.J.D., A.L., S.C.G., A.V.S.H.), and Viral Pseudotype Unit, Faculty of Science and Technology, University of Westminster (E.M.B., E.W.), and Virus Reference Department, Public Health Agency (D.S., R.T.), London - all in the United Kingdom; the Institute of Virology, Philipps University Marburg (S.K.F., T.S., N.B., V.K., S.B.), and German Center for Infection Research, Partner Site Giessen-Marburg-Langen (S.B.), Marburg, and Bavarian Nordic, Martinsried (A.V., P.C.) - all in Germany; GlaxoSmithKline Biologicals, Rixensart, Belgium (F.R., I.D.R., W.R.B.); ReiThera, Rome (A.N., L.S., S.C., A.F., S.D.M.), and CEINGE and the Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples (A.N.) - both in Italy; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda (N.J.S., D.A.S., O.T.M., J.E.L., R.M.S., B.S.G., R.A.K.), and the Center for Vaccine Development, University of Maryland School of Medicine, Baltimore (M.M.L.) - both in Maryland; and Keires, Basel, Switzerland (R.C.).

View Article and Find Full Text PDF
April 2016

Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.

Lancet Infect Dis 2015 Mar 14;15(3):356-9. Epub 2015 Jan 14.

Jenner Institute, University of Oxford, Oxford, UK.

View Article and Find Full Text PDF
March 2015

A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression.

PLoS One 2013 21;8(11):e81317. Epub 2013 Nov 21.

Centre de Recerca en Sanitat Animal, Universitat autonoma de Barcelona-Investigación y tecnología Agroalimentarias, Campus de la Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain.

View Article and Find Full Text PDF
January 2015

Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.

PLoS One 2013 9;8(7):e67888. Epub 2013 Jul 9.

Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.

View Article and Find Full Text PDF
February 2014

Poxvirus vectors.

Vaccine 2013 Sep 5;31(39):4217-9. Epub 2013 Jul 5.

View Article and Find Full Text PDF
September 2013

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.

Vaccine 2013 Sep 5;31(39):4223-30. Epub 2013 Jun 5.

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford OX3 7DQ, UK.

View Article and Find Full Text PDF
September 2013

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.

PLoS One 2013 3;8(5):e62778. Epub 2013 May 3.

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.

View Article and Find Full Text PDF
November 2013

Clinical development of Modified Vaccinia virus Ankara vaccines.

Authors:
Sarah C Gilbert

Vaccine 2013 Sep 21;31(39):4241-6. Epub 2013 Mar 21.

Jenner Institute, University of Oxford, ORCRB, OX3 7DQ, UK.

View Article and Find Full Text PDF
September 2013

No easy route to a pandemic influenza vaccine.

Authors:
Sarah C Gilbert

Lancet Infect Dis 2013 Mar 29;13(3):188-9. Epub 2013 Jan 29.

Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.

View Article and Find Full Text PDF
March 2013

Influenza vaccines and immunopathology.

Authors:
Sarah C Gilbert

Expert Rev Vaccines 2012 Aug;11(8):873-5

View Article and Find Full Text PDF
August 2012

Advances in the development of universal influenza vaccines.

Authors:
Sarah C Gilbert

Influenza Other Respir Viruses 2013 Sep 24;7(5):750-8. Epub 2012 Sep 24.

Jenner Institute, University of Oxford, Oxford, UK.

View Article and Find Full Text PDF
September 2013

Incidental diagnosis in healthy clinical trial subjects.

Clin Transl Sci 2012 Aug 6;5(4):348-50. Epub 2012 Mar 6.

Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Drive, OX3 7LJ, United Kingdom.

View Article and Find Full Text PDF
August 2012

Distinguishing malaria and influenza: early clinical features in controlled human experimental infection studies.

Travel Med Infect Dis 2012 Jul 22;10(4):192-6. Epub 2012 Apr 22.

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, UK.

View Article and Find Full Text PDF
July 2012

T-cell-inducing vaccines - what's the future.

Authors:
Sarah C Gilbert

Immunology 2012 Jan;135(1):19-26

Jenner Institute, University of Oxford, UK.

View Article and Find Full Text PDF
January 2012

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

PLoS One 2011 13;6(5):e20067. Epub 2011 May 13.

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.

View Article and Find Full Text PDF
October 2011

Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria.

Cell Host Microbe 2011 Mar 16;9(3):252. Epub 2011 Mar 16.

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.

View Article and Find Full Text PDF
March 2011